Corcept Therapeutics Incorporated (CORT) Q4 2020 Earnings Call Transcript
CORT earnings call for the period ending December 31, 2020.
Corcept Therapeutics
CORT
CORT
$25.56
-$1.04
-3.9%
Price as of February 25, 2021, 9:00 p.m. EST
View Interactive CORT Charts
A pharmaceutical company which is engaged in the development of drugs for the treatment of severe psychiatric and metabolic diseases.
Interactive Chart
News & Analysis: Corcept Therapeutics
The Fool has written over 100 articles on Corcept Therapeutics.
Why Corcept Therapeutics Soared 37% Higher in September
A patent decision on its cortisol therapy Korlym is expected to be rendered next month.
2 Monster Stocks in the Making
These two biotechs have the potential to become giants within their domains.
Corcept Therapeutics Incorporated (CORT) Q2 2020 Earnings Call Transcript
CORT earnings call for the period ending July 31, 2020.
Should You Climb on Board the Corcept Therapeutics Train?
This biotech company has seen huge growth over the past five years.
Corcept Therapeutics Incorporated (CORT) Q1 2020 Earnings Call Transcript
CORT earnings call for the period ending March 31, 2020.
Corcept Therapeutics Incorporated (CORT) Q4 2019 Earnings Call Transcript
CORT earnings call for the period ending December 31, 2019.
Here's Why Corcept Therapeutics Stock Hit the Bricks Today
The company's fight to keep generic competition at bay took a turn for the worse.
Corcept Therapeutics Incorporated (CORT) Q3 2019 Earnings Call Transcript
CORT earnings call for the period ending September 30, 2019.
Corcept Therapeutics Incorporated (CORT) Q2 Earnings Call Transcript
CORT earnings call for the period ending June 30, 2019.
